Dedicated to human health with a network covering more than 50 countries and regions.
bioperfectus
A public listed company specialized in diagnostic solution of infectious diseases and many others.
BioPerfectus
Nucleic Acid Extraction Solution -
to ensure a consolidated start for PCR
넳넲
BioPerfectus, a public listed company at Shanghai Stock Exchange (SSE:688399), is one of the leading molecular diagnostic solution providers in global in-vitro diagnostic market since 2010.
ABOUT US
One of the leading molecular diagnostic solution providers in global in-vitro diagnostic market since 2010.
PRODUCTS
Bioperfectus is key real-time PCR product supplier for Chinese disease prevention and control market.
NEWS
Company news and information of Jiangsu Bioperfectus Technology Co. Ltd..
The joint PHE Porton Down & University of Oxford SARS-CoV-2 test development and validation cell has published the outcome of the evaluation of rapid diagnostic assays for specific SARS-CoV-2 antigens (lateral flow devices) on Wednesday.
We Bioperfectus are proud to announce that our Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit has been granted approval by BfArM (The Germany Federal Institute for Drugs and Medical Devices)